These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22772325)

  • 21. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
    Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
    Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
    [No Abstract]   [Full Text] [Related]  

  • 22. A case of rituximab-induced hepatitis.
    Del Prete CJ; Cohen NS
    Cancer Biother Radiopharm; 2010 Dec; 25(6):747-8. PubMed ID: 21204770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.
    Zarkhin V; Lovelace PA; Li L; Hsieh SC; Sarwal MM
    Transplantation; 2011 May; 91(9):1010-8. PubMed ID: 21403590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antenatal intravenous immunoglobulin in chronic immune thrombocytopenic purpura: case report and literature review.
    Howman RA; Barr AL; Shand AW; Dickinson JE
    Fetal Diagn Ther; 2009; 25(1):93-7. PubMed ID: 19218809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
    Zhu YC; Wang W; Zhou YH; Wang XM; Wang X; Wang YL; Sun GZ; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Idiopathic thrombopenic purpura and pregnancy].
    el Hajoui S; Nabil S; Khachani M; Kaddioui S; Alami MH; Bezad R; Alaoui MT
    Tunis Med; 2003 Mar; 81(3):213-6. PubMed ID: 12793075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab-induced toxicity.
    Mumoli N; Cei M
    QJM; 2011 Mar; 104(3):265. PubMed ID: 20228132
    [No Abstract]   [Full Text] [Related]  

  • 28. The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
    Quan C; ZhangBao J; Lu J; Zhao C; Cai T; Wang B; Yu H; Qiao J; Lu C
    J Neuroimmunol; 2015 May; 282():45-53. PubMed ID: 25903728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe autoimmune thrombocytopenia in pregnancy].
    Widmer A; Brühwiler H; Krause M; Lüscher KP
    Z Geburtshilfe Neonatol; 1999; 203(6):258-60. PubMed ID: 10612200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy.
    Zhu B; Huang J
    Pediatr Nephrol; 2011 Apr; 26(4):637-8. PubMed ID: 21046167
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunologic mechanisms involved in rituximab failure during adult immune thrombocytopenia].
    Audia S; Saas P; Bonnotte B
    Med Sci (Paris); 2014 Mar; 30(3):239-42. PubMed ID: 24685209
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M; Iki S; Urabe A
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
    Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombocytopenia in newborn infants caused by autoimmune thrombocytopenic purpura in their mothers].
    Mordasewicz-Goliszewska M
    Wiad Lek; 1992 Apr; 45(7-8):270-4. PubMed ID: 1462587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of pneumococcal vaccination in adult immune thrombocytopenia patients exposed to rituximab or to splenectomy.
    Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Adoue D
    Eur J Haematol; 2013 May; 90(5):438-9. PubMed ID: 23444912
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of Rasmussen encephalitis treated with rituximab.
    Thilo B; Stingele R; Knudsen K; Boor R; Bien CG; Deuschl G; Lang N
    Nat Rev Neurol; 2009 Aug; 5(8):458-62. PubMed ID: 19657347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with rituximab in benign and malignant hematologic disorders in children.
    Giulino LB; Bussel JB; Neufeld EJ;
    J Pediatr; 2007 Apr; 150(4):338-44, 344.e1. PubMed ID: 17382107
    [No Abstract]   [Full Text] [Related]  

  • 39. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura.
    Koyama S; Tomimatsu T; Kanagawa T; Kumasawa K; Tsutsui T; Kimura T
    Am J Hematol; 2012 Jan; 87(1):15-21. PubMed ID: 22031338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe steroid-dependent idiopathic angioedema with response to rituximab.
    Ghazan-Shahi S; Ellis AK
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):374-6. PubMed ID: 21962102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.